Comparing the time to odontogenic sinusitis resolution after primary dental treatment versus endoscopic sinus surgery.


Comparing the time to odontogenic sinusitis resolution after primary dental treatment versus endoscopic sinus surgery.
Concurrent septoplasty and younger age were associated with increased opioid usage, although the majority of FESS patients did not take more than five opioid tablets after surgery.

The reboot approach significantly reduced nasal polyp recurrence for 30 months postoperatively compared to the current mucosa-sparing approach.
HTA and the Systematic Human Error Reduction and Prediction Approach (SHERPA) are valuable tools to highlight potential errors in functional endoscopic sinus surgery (FESS).
Olfaction can be improved by sinus surgery in about every second chronic rhinosinusitis (CRS) patient.
A look at how effective systemic tranexamic acid is compared to a control in blood loss, operative time, and surgical field and incidence of postoperative emesis and thromboembolism in endoscopic sinus surgery (ESS).
Tissue eosinophil aggregates appear to be the largest driving factor for increased prednisone requirements after sinus surgery to control mucosal disease than the mere presence of eosinophils.
The septal deformity grading (SDG) system may be valuable when used in conjunction with subjective data gathered from the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire.
Patients with long-term symptom duration reported the greatest mean postoperative quality of life improvement.
Presence of glaucoma the real clinical adverse event of concern when using intranasal corticosteroids for adult patients with rhinitis.